GENEMEDICINE grants Corange $2.1 million exclusive option for cancer alliance.THE WOODLANDS, Texas--(BUSINESS WIRE)--Feb. 13, 1995--GENEMEDICINE INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :GMED) announced Monday that the company has granted Corange International Ltd., the parent company of Boehringer Mannheim, an exclusive option to enter into a corporate alliance to develop certain non-viral gene medicines for application in the field of cancer. With the execution of the option agreement, Corange paid GENEMEDICINE $2.1 million to maintain the option until June 30, 1995, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. GENEMEDICINE President and Chief Executive Officer Eric Tomlinson, D.Sc., Ph.D. "Boehringer Mannheim, with its worldwide, recognized expertise in biotechnology, is very confident that this potential corporate alliance with GENEMEDICINE could significantly advance the treatment of cancer within a short time frame," said Dr. Gerry Moller, president of the therapeutic division of Boehringer Mannheim. "In our judgement, GENEMEDICINE has the most promising portfolio of technologies and products in the field of non-viral gene therapies." GENEMEDICINE is developing a new class of pharmaceutical products that incorporates genes, called "gene medicines." The company's proprietary gene medicines are based on two technologies -- gene expression systems and synthetic gene delivery systems -- that combine to control the location, level and duration of gene expression within the body. GENEMEDICINE's technologies have potential application in the development of gene therapy methods for a wide range of genetic and acquired diseases and disorders, including certain blood, muscle, inflammatory, pulmonary pulmonary /pul·mo·nary/ (pool´mo-nar?e) 1. pertaining to the lungs. 2. pertaining to the pulmonary artery. pul·mo·nar·y adj. Of, relating to, or affecting the lungs. , cardiovascular cardiovascular /car·dio·vas·cu·lar/ (-vas´ku-ler) pertaining to the heart and blood vessels. car·di·o·vas·cu·lar adj. Abbr. and metabolic disorders Noun 1. metabolic disorder - a disorder or defect of metabolism disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; "everyone gets stomach upsets from time to time" and cancers, and in the development of gene vaccines for a variety of clinical applications. CONTACT: GENEMEDICINE INC., The Woodlands Angela Goodwin, 713/364-1150 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion